Table 1 Clinical characteristics and disease markers in 99 patients with early RA and 32 healthy controls
From: Lymphocyte activation gene 3 is increased and affects cytokine production in rheumatoid arthritis
Early RA, baseline | Early RA, 12 months | Healthy controls | |
|---|---|---|---|
Gender, women (%) | 65 (66) | 22 (67) | |
Age (years) | 55 (46–64) | 56 (51–64) | |
DAS28CRP | 5.6 (4.8–6.5) | 2.0 (1.8–2.8) | |
Swollen joint count (0–28) | 8 (5.0–13) | 0 (0–0) | |
Tender joint count (0–28) | 11 (7.0–18) | 0 (0–1.0) | |
Swollen joint count (0–40) | 11 (7.0–19) | 0 (0–0) | |
Tender joint count (0–40) | 18 (11–25) | 0 (0–2.3) | |
VAS doctor global (0–100 mm) | 53 (38–73) | 2.0 (0–10) | |
CRP (mg/ml) | 15 (7.0–49) | 7.0 (7.0–8.0) | |
CDAI (0.7–82) | 32 (23–44) | 2.4 (0.28–5.4) | |
IgM-RF (% positive) | 67.7 | – | |
Anti-CCP (% positive) | 58.6 | – | |
TSS (% positive) | 20.0 | 81.8 | |
ΔTSS | – | 1 (0–3) |